Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
PETALUMA, Calif., March 23, 2026 (GLOBE NEWSWIRE) -- Solful, a premium cannabis brand with award-winning dispensaries in San Francisco, Sebastopol, and Healdsburg, will open its fourth retail...
-
MALVERN, Pa., March 19, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral...
-
Preliminary Phase 1 Study Results Show Strong Anti-Tumor Activity and Favorable Safety Profile for First-in-Class Small Molecule MYB mRNA Degrader No Approved Treatment Options for Patients with...
-
EDR killers are a fundamental part of modern ransomware intrusions; affiliates prefer a short, reliable window to run encryptors rather than constantly modifying payloads.Affiliates, not operators,...
-
EDR killers are a fundamental part of modern ransomware intrusions; affiliates prefer a short, reliable window to run encryptors rather than constantly modifying payloads.Affiliates, not operators,...
-
PURCHASE, N.Y., March 17, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative...
-
Solve GNE highlights new research, expanded funding efforts, and progress toward a Phase I clinical trial for GNE myopathy.
-
Novel and potent catalytic approach that directly clears amyloid on the inside of neurons as well as reduces amyloid plaques with the potential to be superior to monoclonal antibodies and restore...
-
BTCS Strategically Revises 2026 Executive Performance Incentive Program to Focus on Profitability
-
FullPAC Named Signature Sponsor of the 2026 PolliesCEO Travis Trawick to Address Modernization of Political Outreach Tech VIRGINIA BEACH, VA, March 16, 2026 (GLOBE NEWSWIRE) -- FullPAC, Inc....